Strode Quoted on Pfizer Deal to Buy Hospira

05 February 2015 Chicago Tribune News

Chicago Tribune

Partner Roger Strode was quoted in a Chicago Tribune article, “Hospira Stock Soars as Pfizer Says it will Buy for $15.23 Billion,” on February 5, 2015. The article discussed details surrounding pharmaceutical giant Pfizer’s plans to buy Illinois drug maker Hospira. Strode was quoted saying, “The shareholders of Hospira are going to be really well off. Hospira’s stock has zoomed already. It’s a huge benefit to them.”

Strode also touched on the outlook for mergers and acquisitions in the pharmaceutical industry and said, “Pharma has been very robust. A lot of companies have done well and they’re sitting on a lot of cash. We’re still in the middle of a bull market.”

Related Services

Insights

Text Messages, EDiscovery, and the New Threat to Privacy
21 November 2019
CMS Proposes Enhanced Scrutiny over Medicaid Supplemental Payments
20 November 2019
Health Care Law Today
The Purpose of a Corporation
November 2019
Legal News: Business Law
Should This Be a "Mobility" Industry Blog?
19 November 2019
Dashboard Insights
PATH Summit 2019
18-20 December 2019
Arlington, VA
Madison CLE Days
18-19 December 2019
Madison, WI
MedTech Impact Expo & Conference
13-15 December 2019
Las Vegas, NV
HFMA MA-RI Annual Compliance Update
12 December 2019
Boston, MA